skip to main content
Language:
Results 1 2 3 4 5 next page
Refined by: subject: Middle Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma
Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma
Material Type:
Article 		Add to e-Shelf

Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma

Hass, Holger G ; Vogel, Ulrich ; Scheurlen, Michael ; Jobst, Jürgen

Anticancer research, 2016-10, Vol.36 (10), p.5087-5095 [Peer Reviewed Journal]

Greece

Full text available

Citations Cited by
2
Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group
Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group
Material Type:
Article 		Add to e-Shelf

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

MOOSMANN, Nicolas ; FISCHER VON WEIKERSTHAL, Ludwig ; SCHULZE, Mathias ; ABENHARDT, Wolfgang ; PUCHTLER, Gerhard ; KAPPAUF, Herbert ; MITTERMÜLLER, Johann ; HABERL, Christopher ; SCHALHORN, Andreas ; JUNG, Andreas ; STINTZING, Sebastian ; HEINEMANN, Volker ; VEHLING-KAISER, Ursula ; STAUCH, Martina ; HASS, Holger G ; DIETZFELBINGER, Herrmann ; ORUZIO, Daniel ; KLEIN, Stefan ; ZELLMANN, Klaus ; DECKER, Thomas

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1050-1058 [Peer Reviewed Journal]

Alexandria, VA: American Society of Clinical Oncology

Full text available

Citations Cited by
3
Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays
Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays
Material Type:
Article 		Add to e-Shelf

Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays

Hass, Holger G ; Vogel, Ulrich ; Scheurlen, Michael ; Jobst, Jürgen

Gut and Liver, 2018, 12(3), , pp.306-315 [Peer Reviewed Journal]

Korea (South): Editorial Office of Gut and Liver

Full text available

Citations Cited by
4
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
Material Type:
Article 		Add to e-Shelf

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

NEHLS, O ; OETTLE, H ; GREGOR, M ; KLUMP, B ; HARTMANN, J. T ; HOFHEINZ, R.-D ; HASS, H. G ; HORGER, M. S ; KOPPENHÖFER, U ; HOCHHAUS, A ; STIELER, J ; TROJAN, J

British journal of cancer, 2008-01, Vol.98 (2), p.309-315 [Peer Reviewed Journal]

Basingstoke: Nature Publishing Group

Full text available

Citations Cited by
5
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX
Material Type:
Article 		Add to e-Shelf

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

NEHLS, O ; OKECH, T ; HARTMANN, J. T ; PORSCHEN, R ; GREGOR, M ; KLUMP, B ; HSIEH, C.-J ; ENZINGER, T ; SARBIA, M ; BORCHARD, F ; GRUENAGEL, H.-H ; GACO, V ; HASS, H. G ; ARKENAU, H. T

British journal of cancer, 2007-05, Vol.96 (9), p.1409-1418 [Peer Reviewed Journal]

Basingstoke: Nature Publishing Group

Full text available

Citations Cited by
6
Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B
Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B
Material Type:
Article 		Add to e-Shelf

Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B

Hass, Holger G ; Bock, Thomas ; Nehls, Oliver ; Kaiser, Stephan

Journal of gastroenterology, 2009-08, Vol.44 (8), p.871-877 [Peer Reviewed Journal]

Japan: Japan : Springer Japan

Full text available

Citations Cited by
7
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
Material Type:
Article 		Add to e-Shelf

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

von Einem, J. C. ; Heinemann, V. ; von Weikersthal, L. Fischer ; Vehling-Kaiser, U. ; Stauch, M. ; Hass, H. G. ; Decker, T. ; Klein, S. ; Held, S. ; Jung, A. ; Kirchner, T. ; Haas, M. ; Holch, J. ; Michl, M. ; Aubele, P. ; Boeck, S. ; Schulz, C. ; Giessen, C. ; Stintzing, S. ; Modest, D. P.

Journal of cancer research and clinical oncology, 2014-09, Vol.140 (9), p.1607-1614 [Peer Reviewed Journal]

Berlin/Heidelberg: Springer Berlin Heidelberg

Full text available

Citations Cited by
8
Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case Report
Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case Report
Material Type:
Article 		Add to e-Shelf

Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case Report

Hass, H G ; Denzlinger, C

Zeitschrift für Gastroenterologie, 2009-01, Vol.47 (1), p.27-29 [Peer Reviewed Journal]

Germany

Full text available

Citations Cited by
9
Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial
Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial
Material Type:
Article 		Add to e-Shelf

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

Nehls, O ; Klump, B ; Arkenau, H T ; Hass, H G ; Greschniok, A ; Gregor, M ; Porschen, R

British journal of cancer, 2002-09, Vol.87 (7), p.702-704 [Peer Reviewed Journal]

England: Nature Publishing Group

Full text available

Citations Cited by
10
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC) – Potential implications for clinical management and treatment decisions
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC) – Potential implications for clinical management and treatment decisions
Material Type:
Article 		Add to e-Shelf

DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC) – Potential implications for clinical management and treatment decisions

Hass, Holger G ; Schmidt, Andreas ; Nehls, Oliver ; Kaiser, Stephan

Oral oncology, 2008-01, Vol.44 (1), p.78-85 [Peer Reviewed Journal]

Oxford: Elsevier Ltd

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Creation Date 

From To
Refine
  1. Before1995  (7)
  2. 1995To2001  (5)
  3. 2002To2007  (7)
  4. 2008To2014  (17)
  5. After 2014  (16)
  6. More options open sub menu

Language 

  1. English  (49)
  2. Japanese  (8)
  3. German  (3)
  4. More options open sub menu

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far